Sage Journals: Discover world-class research

Abstract

Keywords

Ranibizumab aflibercept neovascular age-related macular degeneration macular atrophy

Get full access to this article

View all access options for this article.

References

Oliveira

Farinha

Rodriguez

, et al. Macular atrophy in neovascular age-related macular degeneration during first year of treatment: incidence and risk factors. Eur J Ophthalmol. Epub ahead of print 27 February 2020. DOI: 10.1177/1120672120908718.

Călugăru

Correspondence. Retina 2019; 39(12): e60–e62.

Călugăru

Călugru

. Comment on “Intravitreal conbercept injection for neovascular age-related macular degeneration.” Int J Ophthalmol 2020; 13(2); 362–364.

Călugăru

High-frequency aflibercept injections in persistent neovascular age-related macular degeneration. Graefe’s Arch Clin Exp Ophthalmol 2017; 255(10): 2067–2068.

Călugăru

Treat-and-extend therapy using aflibercept for neovascular age-related macular degeneration: a prospective clinical trial. Am J Ophthalmol 2017; 182(4): 204–205.

Macular atrophy development in neovascular age-related macular degeneration

Abstract

Keywords

Get full access to this article

References